Literature DB >> 3029010

Elimination of plasmids from Enterobacteriaceae by 4-quinolone derivatives.

Y Michel-Briand, V Uccelli, J M Laporte, P Plesiat.   

Abstract

Twelve 4-quinolones (cinoxacin, ciprofloxacin, enoxacin, flumequin, nalidixic acid, norfloxacin, oxolinic acid, pefloxacin, pipemidic acid, rosoxacin, and piromidic and beta-hydroxypiromidic acids) and novobiocin, were used at subinhibitory concentrations to eliminate from Escherichia coli 11 antibiotic resistance plasmids belonging to different incompatibility groups. The 12 4-quinolones were also tested for their ability to cure virulence plasmids from five species of Enterobacteriaceae. All quinolones eliminated three antibiotic resistance plasmids (R446b, R386, S-a) and one virulence plasmid (pWR105), but at a low rate. Optimal curing of antibiotic resistance plasmids was obtained in human urine. Two virulence plasmids (pWR24 and pWR110) were eliminated only by flumequin and pefloxacin. Novobiocin eliminated three antibiotic resistance plasmids (R446b, R386, pIP24). The variable and low level of plasmid loss may be explained by the induction of the recA system. In addition, the inability to eliminate certain plasmids could be due to their presence in high numbers per cell.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3029010     DOI: 10.1093/jac/18.6.667

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  Mechanisms that may account for differential antibiotic susceptibilities among Coxiella burnetii isolates.

Authors:  M R Yeaman; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 2.  Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J M Henwood; J P Monk
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

3.  tRNA modification activity is necessary for Tet(M)-mediated tetracycline resistance.

Authors:  V Burdett
Journal:  J Bacteriol       Date:  1993-11       Impact factor: 3.490

4.  High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium.

Authors:  G M Eliopoulos; C Wennersten; S Zighelboim-Daum; E Reiszner; D Goldmann; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

5.  Elimination of plasmids pKM 101 and F'lac from Salmonella typhimurium and Escherichia coli by bisammonium salt. The effect of outer membrane pattern.

Authors:  P Sýkora; V Ceplíková; Z Foltýnová; L Horniak; L Ebringer
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

Review 6.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 7.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

8.  Effects of subinhibitory concentrations of antibiotics on biological properties of Salmonella typhimurium.

Authors:  L Majtánová; A Hostacká; V Majtán
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

Review 9.  Targeting Plasmids to Limit Acquisition and Transmission of Antimicrobial Resistance.

Authors:  Corneliu Ovidiu Vrancianu; Laura Ioana Popa; Coralia Bleotu; Mariana Carmen Chifiriuc
Journal:  Front Microbiol       Date:  2020-05-06       Impact factor: 5.640

Review 10.  Strategies to combat antimicrobial resistance: anti-plasmid and plasmid curing.

Authors:  Michelle M C Buckner; Maria Laura Ciusa; Laura J V Piddock
Journal:  FEMS Microbiol Rev       Date:  2018-11-01       Impact factor: 16.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.